Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study

Shubham Pant; Martin Schüler; Gopa Iyer; Olaf Witt; Toshihiko Doi; Josep Tabernero; David A. Reardon; Christophe Massard; Anna Minchom; Iwona Ługowska; Omar Carranza; Dirk Arnold; Martin Gutierrez; Helen Winter; Kim Stuyckens; Lauren Crow; Saltanat Najmi; Constance Hammond; Shibu Thomas; Ademi Santiago-Walker; Spyros Triantos; Hussein Sweiti; Yohann Loriot; Omar Carranza; Martin Alberto Greco; Jermaine Coward; Anthony M. Joshua; Christos S. Karapetis; Christopher D. Hart; Alison Y. Zhang; Hans Prenen; Jean‐Charles Goeminne; Jean‐Pascal Machiels; Sylvie Rottey; Marcelo Corassa; Graziela Zibetti Dal Molin; Katsuki Arima Tiscoski; Denis L. Jardim; Milena Perez Mak; Wei Fu; Herui Yao; Jing Huang; Haiping Jiang; Baoshi Chen; Dong Yan; Yu Yang; Yohann Loriot; Christophe Le Tourneau; Nicolas Penel; Sébastien Salas; Jean Yves Blay; Pierre-Emmanuel Brachet; Xavier Durando; Sheik Emambux; Alain Ravaud; Gunnar Folprecht; Dirk Arnold; Martin Schüler; Marit Ahrens; Alexander Golf; Georg Martin Haag; Florian Lordick; Alexander Desuki; Marina Elena Cazzaniga; Fortunato Ciardiello; Michèle Milella; Takafumi Koyama; Yoshiki Hirooka; Wataru Okamoto; Kenjiro Aogi; Yasutoshi Kuboki; Jung-Yun Lee; Sung‐Bae Kim; Myung‐Ju Ahn; Jong Hee Chang; Yongman Kim; Do‐Hyun Nam; Jaesung Park; Iwona Ługowska; Luis Paz‐Ares; Víctor Moreno; Andrés Cervantes; Mariona Calvo; Alejandro Falcón; Antonio González; Josep Tabernero; A. Martinez Bueno; Javier García-Corbacho; Federico Longo; Chia‐Jui Yen; Jen‐Shi Chen; Ming‐Feng Hou; Yee Chao; Kun‐Ming Rau; Tai‐Jan Chiu; Yin‐Hsun Feng; Chih‐Hung Hsu; Wen‐Tsung Huang

doi:10.1016/s1470-2045(23)00275-9

Related publications

Article2020

Pazopanib for treatment of typical solitary fibrous tumours: a multicentre, single-arm, phase 2 trial

Javier Martín‐Broto, Josefina Cruz, Nicolas Penel, Axel Le Cesne, Nadia Hindi, Pablo Luna, David S. Moura, Daniel Bernabéu, Enrique de Álava, José Antonio López‐Guerrero, Joaquı́n Dopazo, María Peña-Chilet, Antonio Gutiérrez, Paola Collini, Marie Karanian, Andrés Redondo, Antonio López–Pousa, Giovanni Grignani, Juan Díaz‐Martín, David Marcilla, Antonio Fernández‐Serra, Cristina González‐Aguilera, Paolo G. Casali, Jean Yves Blay, Silvia Stacchiotti

Article2012

Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours

Stan B. Kaye, Steinar Aamdal, Richard D. Jones, Gilles Freyer, Éric Pujade-Lauraine, Elisabeth G.E. de Vries, Jorge Barriuso, Shahneen Sandhu, Daniel S.W. Tan, V Hartog, Bart C. Kuenen, Rita Ruijter, Gunnar B. Kristensen, Marta Nyakas, Sophie Barrett, Wendy Burke, D Pietersma, Melissa K. Stuart, Ugochi Emeribe, Epie Boven

Article2016

Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma

Kenji Ikeda, Masatoshi Kudo, Seiji Kawazoe, Yukio Osaki, Masafumi Ikeda, Takuji Okusaka, Toshiyuki Tamai, Takuya Suzuki, Takashi Hisai, Seiichi Hayato, Kiwamu Okita, Hiromitsu Kumada

Article2018

[ 177 Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study

Michael S. Hofman, John Violet, Rodney J. Hicks, Justin Ferdinandus, Sue Ping Thang, Tim Akhurst, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Declan G. Murphy, Peter Eu, Price Jackson, Mark Scalzo, Scott Williams, Shahneen Sandhu

Article2015

The AfFIRM Study: A multicenter phase 2 study of single-agent filanesib (ARRY-520) in patients with advanced multiple myeloma.

Sagar Lonial, Michel Delforge, Hermann Einsele, Philippe Moreau, Martin Kaiser, Meletios A Dimopoulos, Albert Oriol, M Gyger, Brandi Hilder, Ann Marie Ptaszynski, Roger Aitchison, Robert Z. Orlowski